Lucy A. Godley
Affiliations: | Cancer Biology | University of Chicago, Chicago, IL |
Area:
Oncology, Cell BiologyGoogle:
"Lucy Godley"Children
Sign in to add traineeKelly R. Ostler | grad student | 2012 | Chicago |
Erika Moen | grad student | 2014 | Chicago |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Stubbins RJ, Korotev S, Godley LA. (2022) Germline CHEK2 and ATM Variants in Myeloid and Other Hematopoietic Malignancies. Current Hematologic Malignancy Reports |
Samra N, Toubiana S, Yttervik H, et al. (2021) RBL2 bi-allelic truncating variants cause severe motor and cognitive impairment without evidence for abnormalities in DNA methylation or telomeric function. Journal of Human Genetics |
Toubiana S, Larom G, Smoom R, et al. (2020) Regulation of telomeric function by DNA methylation differs between humans and mice. Human Molecular Genetics |
Cao JZ, Liu H, Wickrema A, et al. (2020) HIF-1 directly induces TET3 expression to enhance 5-hmC density and induce erythroid gene expression in hypoxia. Blood Advances. 4: 3053-3062 |
Kewan T, Noss R, Godley LA, et al. (2020) Inherited Thrombocytopenia Caused by Germline Mutation Should Be Considered in Young Patients With Suspected Myelodysplastic Syndrome. Journal of Investigative Medicine High Impact Case Reports. 8: 2324709620938941 |
Brown AL, Arts P, Carmichael CL, et al. (2020) RUNX1-mutated families show phenotype heterogeneity and a somatic mutation profile unique to germline predisposed AML. Blood Advances. 4: 1131-1144 |
Wu D, Luo X, Feurstein S, et al. (2020) How I curate: applying American Society of Hematology-Clinical Genome Resource Myeloid Malignancy Variant Curation Expert Panel rules for RUNX1 variant curation for germline predisposition to myeloid malignancies. Haematologica |
Qiu Z, Lin AP, Jiang S, et al. (2020) MYC Regulation of D2HGDH and L2HGDH Influences the Epigenome and Epitranscriptome. Cell Chemical Biology |
Cahill KE, Karimi YH, Karrison TG, et al. (2020) A phase 1 study of azacitidine with high-dose cytarabine and mitoxantrone in high-risk acute myeloid leukemia. Blood Advances. 4: 599-606 |
Kraft IL, Trottier AM, Steinhardt GF, et al. (2020) Using sequential next-generation sequencing assays to identify germline cancer predisposition variants. Journal of Clinical Oncology. 38: 1581-1581 |